Hydroxybenzamide derivatives and their use as inhibitors of HSP90

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9914719
APP PUB NO 20150045362A1
SERIAL NO

14467946

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides compounds of the formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTEX THERAPEUTICS LTDBRITAIN CAMB CAMBRIDGE CAMBRIDGESHIRE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carr, Maria Grazia Luton, GB 29 434
Chessari, Gianni Cambridge, GB 50 482
Congreve, Miles Stuart Cambridge, GB 132 1216
Downham, Robert Cambridge, GB 25 140
Frederickson, Martyn Cambridge, GB 28 259
Murray, Christopher William Cambridge, GB 61 981
Navarro, Eva Figueroa Cambridge, GB 21 278
O'Brien, Michael Alistair Hertz, GB 40 533
Phillips, Theresa Rachel Macclesfield, GB 7 89
Woodhead, Andrew James Cambridge, GB 38 825
Woolford, Alison Jo-Anne Cambridge, GB 46 452

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 13, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 13, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00